Peficitinib, a JAK Inhibitor, in the Treatment of Moderate-to-severe Rheumatoid Arthritis in Methotrexate-inadequate Responders
Arthritis & Rheum 2016; ePub ahead of print
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Arthritis & Rheum 2016; ePub ahead of print
Ann Rheum Dis 2016;75:1979–83
Arthritis Rheumatol 2016. DOI 10.1002/art.39953. Accepted article
Arthritis Res Ther 2016; 18:211. DOI 10.1186/s13075-016-1108-9
Arthritis Res Ther 2016; 18:198. DOI.10.1186/s13075-016-9
Arthritis Care Res 2016; Accepted article. DOI 10.1002/acr.23004
Arthritis Care Res 2016; Accepted article. DOI 10.1002/acr.23008.
Rheumatology (Oxford) 2016; DOI 10.1093/rheumatology/kew325
Arthritis Rheumatol 2016; Accepted article DOI 10.1002/art-39808 [Epub 2016]
Ann Rheum Dis 2016;0:1–7 DOI 10.1136/annrheumdis-2016-209773.